Search for content, post, videos

FDA grants Medivir Rare Pediatric Disease Designation and Orphan Drug Designation

Medivir's selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease Designation (RPDD) as well as Orphan Drug Designation (ODD) for the treatment of Legg-Calvé-Perthes Disease (LCPD). The FDA defines a rare pediatric disease as a serious or life-threatening disease in whi
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.